Publications Office of the EU
Vitamíny I. - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Vitamíny I.

Overview
  • Published
    19/02/2025
  • Deadline
    20/03/2025
  • Opening of tenders
    20/03/2025
  • Awarded
    29/04/2025
  • Today
    18/05/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Institut klinické a experimentální medicíny
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: CZ010 Hlavní město Praha
Business sector (Main CPV)
33616000 Vitamins
Total estimated contract value (excluding VAT)
7,991,500.00 CZK
Total final contract value (excluding VAT)
7,991,500.00
Number of lots
4
Procedure details
Tender reference number
PZ-2025-0000351
Description

Předmětem veřejné zakázky jsou dodávky léčivých přípravků pro parenterální podání s obsahem vitamínů (ATC skupiny B05XC) pro léčbu pacientů ve schválených indikacích dle SPC platného ke dni podání nabídek.

Submission Method
Electronic via:
https://nen.nipez.cz/profil/ikem
Tenders may be submitted
Electronic submission: required
https://nen.nipez.cz/profil/ikem
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
20/03/2025 10:30
Place of performance
CZ010 Hlavní město Praha
CZ Česko
CPV code

33616000 - Vitamins

Lots (4)
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.